Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Non-Current Deffered Revenue (2016 - 2026)

Healthstream has reported Non-Current Deffered Revenue over the past 12 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 18.79% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 18.79% year-over-year, with the annual reading at $1.3 million for FY2025, 18.79% down from the prior year.
  • Non-Current Deffered Revenue was $1.3 million for Q4 2025 at Healthstream, up from $1.3 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $2.9 million in Q4 2022 and troughed at $990000.0 in Q1 2022.
  • The 5-year median for Non-Current Deffered Revenue is $1.6 million (2021), against an average of $1.8 million.
  • Year-over-year, Non-Current Deffered Revenue surged 158.79% in 2023 and then plummeted 39.01% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $1.6 million in 2021, then soared by 85.53% to $2.9 million in 2022, then decreased by 26.15% to $2.2 million in 2023, then fell by 23.7% to $1.7 million in 2024, then fell by 18.79% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Non-Current Deffered Revenue are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025).